Open access
Sep 2026
Profiling EGFR, c‐MET, and B7H3 co‐expression to guide next‐generation dual‐drug conjugate strategies in colorectal cancer
Using B7H3/c‐MET/c‐MET combination therapies that integrate intracellular signaling inhibition with immune checkpoint modulation could potentially extend therapeutic benefits to a wider range of CRC patients.
Ya-Nan Yang, Hui-Yu Li, Shi-Wei Xiao et al.
· The Journal of Pathology: Cl... · 0 citations